|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-03
|
$171,681
|
$103,009
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-07
|
$730,767
|
$116,923
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(ACN 12011-001-00004) FOR CBRG FOR THE CENTER FOR PROSTATE DISEASE RESEARCH
|
ACN12011001
|
$459,666
|
$459,666
|
UNKNOWN, UNKNOWN
|
UNIFORM THE SERVICES UNIVERSITY OF THE HEALTH
|
|
(PQ3) AGEs and Race Specific Tumor Immune Response in Prostate Cancer
|
5R21CA194469-02
|
$140,445
|
$140,445
|
TURNER, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
|
4R01CA180277-04
|
$307,375
|
$307,375
|
LI, XIN
|
NEW YORK UNIVERSITY
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
5R01CA185457-03
|
$1,005,598
|
$1,005,598
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
(PQC4) Habitats in Prostate Cancer
|
5R01CA190105-03
|
$682,812
|
$682,812
|
GILLIES, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
|
5R01CA185509-03
|
$258,128
|
$258,128
|
GHOSH, PARAMITA
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
1P20CA202924-01A1
|
$234,900
|
$82,215
|
WILLIAMS, KEVIN
|
NORTH CAROLINA CENTRAL UNIVERSITY
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-03
|
$191,836
|
$95,918
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192992-03
|
$164,190
|
$114,933
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
1P20CA202925-01A1
|
$259,367
|
$197,119
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-07
|
$997,277
|
$19,946
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
3P20CA192976-02S1
|
$20,000
|
$9,400
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-03
|
$144,556
|
$67,941
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
2U54CA118623-11
|
$1,134,399
|
$499,136
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
2016 AUA Urologic Oncology Research Symposium: ""Forging New Paths in Research to Advance Urologic Oncology
|
1U13CA206383-01
|
$10,000
|
$3,400
|
BEST, CAROLYN
|
AMERICAN UROLOGICAL ASSOCIATION
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
2U54CA118948-11
|
$1,337,658
|
$361,168
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
3U54CA118948-11S1
|
$162,279
|
$14,605
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
3D Prostate Histochemometry to Predict Disease Recurrence
|
1R01CA197516-01A1
|
$405,047
|
$405,047
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
|
5R21CA191725-02
|
$185,077
|
$61,075
|
FREEDMAN, MATTHEW
|
DANA-FARBER CANCER INST
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$134,092
|
$67,046
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
3U54CA155496-05S1
|
$401,250
|
$112,350
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
|
1R01CA200718-01
|
$624,044
|
$624,044
|
EGGLY, SUSAN
|
WAYNE STATE UNIVERSITY
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
7R01CA166894-04
|
$368,984
|
$368,984
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A New Prostate Cancer Treatment to Improve Outcomes and Reduce Side-effects
|
1R41CA210737-01
|
$225,000
|
$225,000
|
FLYNN, RYAN
|
PXALPHA, LLC
|
|
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
|
1R01CA207645-01
|
$555,680
|
$555,680
|
WEBER, WOLFGANG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
A novel strategy to identify prostate cancer biomarkers for patient management
|
7R01CA172603-04
|
$329,925
|
$329,925
|
HUANG, JIAOTI
|
DUKE UNIVERSITY
|
|
A Novel Treatment of Vasomotor Symptoms in Prostate Cancer Patients
|
1R43CA195910-01A1
|
$226,310
|
$226,310
|
NGUYEN, VIEN
|
AGYPHARMA, LLC
|
|
A Phase Ib clinical trial with niclosamide plus abiraterone for Castration Resistant Prostate Cancer (CRPC)
|
1R43CA206668-01
|
$299,986
|
$299,986
|
LIU, CHENGFEI
|
PANDOMEDX, INC.
|
|
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
|
1R01CA200551-01
|
$247,249
|
$247,249
|
PARK, SEAN
|
MAYO CLINIC ROCHESTER
|
|
A Potent Small Molecule Sigma1 Modulator Degrades Androgen Receptor In Castration Resistant Prostate Cancer
|
1R43CA206691-01A1
|
$225,222
|
$225,222
|
LEHR, MARTIN
|
CONTEXT THERAPEUTICS, LLC
|
|
A Randomized Clinical Trial of Exercise for Men with Metastatic Prostate Cancer
|
5R21CA184605-02
|
$206,843
|
$206,843
|
KENFIELD, STACEY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer
|
1R21CA205108-01
|
$162,075
|
$162,075
|
MOHLER, JAMES
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
1R21CA198237-01A1
|
$202,275
|
$40,455
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
AAAPT Technology for Improving Chemotherapy
|
3R43CA183353-01S1
|
$40,000
|
$13,200
|
PANDURANGI, RAGHU
|
SCI-ENGI-MEDCO SOLUTIONS, INC.
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,229,987
|
$61,499
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
$239,266
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
$938
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
$14,999
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
$6,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACN15005-001-0001 NIST NCI EARLY DETECTION RESEARCH NETWORK: BIOMARKER STANDARDIZATION LABORATORY
|
ACN15005001
|
$600,000
|
$600,000
|
UNKNOWN, UNKNOWN
|
NATIONAL INSTITUTE OF STANDARDS & TECHNOLOGY
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$304,350
|
$60,870
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Adaptive resistance to HIF1a inhibition in hypoxia
|
1R01CA207377-01
|
$352,242
|
$116,240
|
QIAN, ZHENG DAVID
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
4R01CA160902-05
|
$492,649
|
$492,649
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention
|
5K05CA175147-03
|
$88,959
|
$88,959
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AIF-mediated Control of Mitochondrial Biogenesis, Metabolism, and Cellular Redox Balance
|
1R15CA206067-01
|
$435,000
|
$435,000
|
WILKINSON, JOHN
|
NORTH DAKOTA STATE UNIVERSITY
|
|
Akt isoform-specific signaling in breast cancer metastasis
|
5R00CA157945-05
|
$241,629
|
$60,407
|
CHIN, YUET MING REBECCA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$95,739
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$33,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Prostate for this search: $240,985,347
|